We are live on ! Find out more
RXL icon

ProShares Ultra Health Care

19 hedge funds and large institutions have $9.44M invested in ProShares Ultra Health Care in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more call options, than puts

Call options by funds: $2.86M | Put options by funds: $907K

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

42% more capital invested

Capital invested by funds: $6.64M → $9.44M (+$2.8M)

19% more funds holding

Funds holding: 1619 (+3)

4.34% more ownership

Funds ownership: 28.88%33.22% (+4.3%)

Holders
19
Holders Change
+3
Holders Change %
+18.75%
% of All Funds
0.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
7
Reduced
4
Closed
Calls
$2.86M
Puts
$907K
Net Calls
+$1.95M
Net Calls Change
+$769K

RXL Hedge Fund Activity: Q3 2017 in Review

19 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra Health Care (RXL) for Q3 2017, worth a combined $9.44M — up 42% from $6.64M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new RXL positions and 0 closed out — a net gain of 3 holders — while 7 added to existing stakes and 4 trimmed.

The largest buyer was Geneos Wealth Management, adding an estimated $627K. The largest seller was Bell Rock Capital, cutting an estimated $41K.

  • 19 institutional investors held ProShares Ultra Health Care (RXL) as of Q3 2017, up from 16 in Q2 2017.
  • Funds reported $9.44M of ProShares Ultra Health Care stock for Q3 2017, up 42% quarter-over-quarter.
  • 3 funds opened new ProShares Ultra Health Care positions in Q3 2017 and 0 closed out, a net change of +3 holders.
  • The largest ProShares Ultra Health Care buyer in Q3 2017 was Geneos Wealth Management, an estimated $627K added.
  • The largest ProShares Ultra Health Care seller in Q3 2017 was Bell Rock Capital, an estimated $41K sold.

Based on aggregated 13F filings for Q3 2017.